Active, not recruitingPHASE2, PHASE3NCT05217628

An Efficacy and Safety Study of Basimglurant (NOE-101) in Patients With Trigeminal Neuralgia.

Studying Trigeminal neuralgia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Noema Pharma AG
Intervention
Basimglurant(drug)
Enrollment
166 enrolled
Eligibility
18-75 years · All sexes
Timeline
20222027

Study locations (30)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05217628 on ClinicalTrials.gov

Other trials for Trigeminal neuralgia

Additional recruiting or active studies for the same condition.

See all trials for Trigeminal neuralgia

← Back to all trials